Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

BACKGROUND: Molecular characterization of prostate cancer (PCa) has revealed distinct subclasses based on underlying genomic alterations occurring early in the natural history of the disease. However, how these early alterations influence subsequent molecular events and the course of the disease ove...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Invest
Asıl Yazarlar: Liu, Deli, Augello, Michael A., Grbesa, Ivana, Prandi, Davide, Liu, Yang, Shoag, Jonathan E., Karnes, R. Jeffrey, Trock, Bruce J., Klein, Eric A., Den, Robert B., Demichelis, Francesca, Davicioni, Elai, Sboner, Andrea, Barbieri, Christopher E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2021
Konular:
Clinical Medicine
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8121518/
https://ncbi.nlm.nih.gov/pubmed/33998599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI147878
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller